Editor's Picks

There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.

Sanofi-Aventis

Sanofi-Aventis

  1. Taxpayers May Pick Up Tab For Drug Ads
    NPR logo NPR 4 days ago

    If Democrats weren't miffed enough at Big Pharma after news reports suggested the industry hiked prices to offset the impact of the overhaul, the flames could be fanned by a new study that finds companies may also have passed advertising costs on to... Full Article at NPR

  2. Lab launches an iPhone app to track and manage diabetes
    The Independent logo The Independent 5 days ago

    In one of the latest forays by the pharmaceuticals industry into mobile technology platforms for chronic disease management, Sanofi-Aventis has launched the iPhone application GoMeals, designed to help diabetics make the healthiest food choices. Full Article at The Independent

  3. Reuters Pictures 2 months ago
    French drugs group Sanofi Aventis Vice President Michel De Wilde (R) and Chief Executive Officer Chris Veihbacher hold a news conference in Paris, September 24, 2009.

    French drugs group Sanofi Aventis Vice President Michel De Wilde (R) and Chief Executive Officer Chris Veihbacher hold a news conference in Paris, September 24, 2009. View Photo »

  4. These recommendations are based upon recently submitted studies by the manufacturer of clopidogrel [Sanofi-Aventis and Bristol-Myers Squibb]
    SOURCE: MedicineNet 1 week ago
  5. Zacks Analyst Blog Highlights: Pozen, Sanofi-Aventis, Bristol-Myers, AstraZeneca and ADC Telecommunications Inc.
    PR-Inside.com logo PR-Inside.com 5 days ago

    2009-11-23 23:09:02 - AZN : ) and ADC Telecommunications Inc. (Nasdaq: ADCT : ). Full Article at PR-Inside.com

  6. Cramer on BloggingStocks: Sanofi has lots of upside catalysts
    Blogging Stocks logo Blogging Stocks 5 days ago

    TheStreet.com's Jim Cramer says it looks like the patent worries aren't so dire after all. Full Article at Blogging Stocks

  7. Sanofi chief bucks conventional pharma wisdom
    FiercePharma 6 days ago

    Last week, the market researchers at Datamonitor took issue with Big Pharma's current emerging-markets love affair, saying sales there are necessarily lower-margin and thus not up to the task of filling in for patent losses. Full Article at FiercePharma

  8. Reuters Pictures 2 months ago
    Chief Executive Officer Chris Veihbacher of French drugs group Sanofi Aventis speaks during a news conference in Paris, September 24, 2009.

    Chief Executive Officer Chris Veihbacher of French drugs group Sanofi Aventis speaks during a news conference in Paris, September 24, 2009. View Photo »

  9. Four international vaccine manufacturers — Novartis, GlaxoSmithKline (GSK), Sanofi-Aventis and Baxter International — have quoted rates to the government
    SOURCE: Hindustan Times 2 weeks ago
  10. Sanofi Aventis Corporate Video
    YouTube Logo YouTube Videos 6 months ago
  11. Sanofi-Aventis Falling Off a Patent Cliff?
    CNBC logo CNBC 1 week ago

    Sanofi-Aventis by its own admission has “a big patent-expiration problem,” Cramer said during Friday’s Mad Money. Full Article at CNBC

  12. Idaho Gets $115,000 From Sanofi-Aventis Settlement
    ABC News logo ABC News 1 week ago

    Idaho's Medicaid Division is getting nearly $115,000 as its share from a nationwide settlement with French drug giant Sanofi-Aventis. Full Article at ABC News

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using our SmartMedia Services platform, which can give you thousands of content-rich, advertiser-friendly pages (like this one) on any topic and with full editorial control. Learn More »

    Our Customers
    prev
    next
  2. Our Products
    Daylife Select

    A point & click tool to create dynamic content portals. Learn More »

  3. Daylife API

    Unlimited smart, customizable content to suit any publisher. Learn More »

  4. Enterprise API

    Use the Daylife Platform to distribute content across your sites. Learn More »

  5. SmartContext

    Weave the web's best content into your own. Learn More »

About Sanofi-Aventis

Wikipedia

There are no results for this module. Edit this module to change the search term used to query Wikipedia

Related Photos

Chief Executive Officer Chris Veihbacher of French drugs group Sanofi Aventis speaks during a news conference in Paris, September 24, 2009. Sanofi announced the results of the collaborative AIDS vaccine trial that has been conducted in Thailand over the past six years.
Pause Play 1/25
prev
  1. French drugs group Sanofi Aventis Vice President Michel De Wilde (R) and Chief Executive Officer Chris Veihbacher hold a news conference in Paris, September 24, 2009. Reuters Pictures 2 months ago

    French drugs group Sanofi Aventis Vice President Michel De Wilde (R) and Chief Executive Officer Chris Veihbacher hold a news conference in Paris, September 24, 2009.

    View Photo »
  2. Chief Executive Officer Chris Veihbacher of French drugs group Sanofi Aventis speaks during a news conference in Paris, September 24, 2009. Sanofi announced the results of the collaborative AIDS vaccine trial that has been conducted in Thailand over the past six years. Reuters Pictures 2 months ago

    Chief Executive Officer Chris Veihbacher of French drugs group Sanofi Aventis speaks during a news conference in Paris, September 24, 2009. Sanofi announced the results of the collaborative AIDS vaccine trial that has been conducted in Thailand over the past six years.

    View Photo »
  3. French drugs group Sanofi Aventis Vice President Michel De Wilde (R) and Chief Executive Officer Chris Veihbacher hold a news conference in Paris, September 24, 2009. Reuters Pictures 2 months ago

    French drugs group Sanofi Aventis Vice President Michel De Wilde (R) and Chief Executive Officer Chris Veihbacher hold a news conference in Paris, September 24, 2009.

    View Photo »
  4. Lindsay Owen-Jones, director of the board at French drugmaker Sanofi Aventis, gestures during the company's shareholders' meeting in Paris April 17, 2009. Reuters Pictures 7 months ago

    Lindsay Owen-Jones, director of the board at French drugmaker Sanofi Aventis, gestures during the company's shareholders' meeting in Paris April 17, 2009.

    View Photo »
  5. French drugmaker Sanofi Aventis Director of the board Lindsay Owen-Jones (R) talks with Chris Veihbacher, their new chief executive officer, during the company's shareholders' meeting in Paris April 17, 2009. Reuters Pictures 7 months ago

    French drugmaker Sanofi Aventis Director of the board Lindsay Owen-Jones (R) talks with Chris Veihbacher, their new chief executive officer, during the company's shareholders' meeting in Paris April 17, 2009.

    View Photo »
  6. French drugmaker Sanofi Aventis President Jean-Francois Dehecq (L) talks with Chris Veihbacher, their new chief executive officer, during the company's shareholders' meeting in Paris April 17, 2009. Reuters Pictures 7 months ago

    French drugmaker Sanofi Aventis President Jean-Francois Dehecq (L) talks with Chris Veihbacher, their new chief executive officer, during the company's shareholders' meeting in Paris April 17, 2009.

    View Photo »
  7. French drugmaker Sanofi Aventis President Jean-Francois Dehecq (L) talks with Chris Veihbacher, their new chief executive officer, during the company's shareholders' meeting in Paris April 17, 2009. Reuters Pictures 7 months ago

    French drugmaker Sanofi Aventis President Jean-Francois Dehecq (L) talks with Chris Veihbacher, their new chief executive officer, during the company's shareholders' meeting in Paris April 17, 2009.

    View Photo »
  8. Chris Viehbacher, Chief Executive Officer of Sanofi-Aventis, speaks during the company's 2008 annual results presentation in Paris February 11, 2009. Reuters Pictures 9 months ago

    Chris Viehbacher, Chief Executive Officer of Sanofi-Aventis, speaks during the company's 2008 annual results presentation in Paris February 11, 2009.

    View Photo »
  9. Chris Viehbacher, Chief Executive Officer of Sanofi-Aventis, speaks during the company's 2008 annual results presentation in Paris February 11, 2009. Reuters Pictures 9 months ago

    Chris Viehbacher, Chief Executive Officer of Sanofi-Aventis, speaks during the company's 2008 annual results presentation in Paris February 11, 2009.

    View Photo »
  10. Chris Viehbacher, Chief Executive Officer of Sanofi-Aventis, attends the company's 2008 annual results presentation in Paris February 11, 2009. Reuters Pictures 9 months ago

    Chris Viehbacher, Chief Executive Officer of Sanofi-Aventis, attends the company's 2008 annual results presentation in Paris February 11, 2009.

    View Photo »
  11. Chris Viehbacher, Chief Executive Officer of Sanofi-Aventis, speaks during the company's 2008 annual results presentation in Paris February 11, 2009. Reuters Pictures 9 months ago

    Chris Viehbacher, Chief Executive Officer of Sanofi-Aventis, speaks during the company's 2008 annual results presentation in Paris February 11, 2009.

    View Photo »
  12. Chris Viehbacher, Chief Executive Officer of Sanofi-Aventis, speaks during the company's 2008 annual results presentation in Paris February 11, 2009. Reuters Pictures 9 months ago

    Chris Viehbacher, Chief Executive Officer of Sanofi-Aventis, speaks during the company's 2008 annual results presentation in Paris February 11, 2009.

    View Photo »
  13. Employees of French pharmaceutical giant Sanofi-Aventis demonstrate in front of their headquarters in Paris on December 4, 2008 to protest against job cuts. In France Sanofi-Aventis has already announced the elimination of 927 jobs, most of them in sales. Getty Images logo Getty Images 12 months ago

    Employees of French pharmaceutical giant Sanofi-Aventis demonstrate in front of their headquarters in Paris on December 4, 2008 to protest against job cuts. In France Sanofi-Aventis has already announced the elimination of 927 jobs, most of them in sales.

    View Photo »
  14. Employees of French pharmaceutical giant Sanofi-Aventis demonstrate in front of their headquarters in Paris on December 4, 2008 to protest against job cuts. In France Sanofi-Aventis has already announced the elimination of 927 jobs, most of them in sales. Getty Images logo Getty Images 12 months ago

    Employees of French pharmaceutical giant Sanofi-Aventis demonstrate in front of their headquarters in Paris on December 4, 2008 to protest against job cuts. In France Sanofi-Aventis has already announced the elimination of 927 jobs, most of them in sales.

    View Photo »
  15. Employees of French pharmaceutical giant Sanofi-Aventis demonstrate in front of their headquarters in Paris on December 4, 2008 to protest against job cuts. In France Sanofi-Aventis has already announced the elimination of 927 jobs, most of them in sales. Getty Images logo Getty Images 12 months ago

    Employees of French pharmaceutical giant Sanofi-Aventis demonstrate in front of their headquarters in Paris on December 4, 2008 to protest against job cuts. In France Sanofi-Aventis has already announced the elimination of 927 jobs, most of them in sales.

    View Photo »
  16. Employees of French pharmaceutical giant Sanofi-Aventis demonstrate in front of their headquarters in Paris on December 4, 2008 to protest against job cuts. In France Sanofi-Aventis has already announced the elimination of 927 jobs, most of them in sales. Getty Images logo Getty Images 12 months ago

    Employees of French pharmaceutical giant Sanofi-Aventis demonstrate in front of their headquarters in Paris on December 4, 2008 to protest against job cuts. In France Sanofi-Aventis has already announced the elimination of 927 jobs, most of them in sales.

    View Photo »
  17. Employees of French pharmaceutical giant Sanofi-Aventis demonstrate in front of their headquarters in Paris on December 4, 2008 to protest against job cuts. In France Sanofi-Aventis has already announced the elimination of 927 jobs, most of them in sales. Getty Images logo Getty Images 12 months ago

    Employees of French pharmaceutical giant Sanofi-Aventis demonstrate in front of their headquarters in Paris on December 4, 2008 to protest against job cuts. In France Sanofi-Aventis has already announced the elimination of 927 jobs, most of them in sales.

    View Photo »
  18. Amer Khoury, director of French pharmaceutical group Sanofi-Aventis site in Lisieux, poses, on October 28, 2009, in Lisieux. The site, created in 1982, is dedicated to the production of medicine containing paracetamol. Getty Images logo Getty Images 1 month ago

    Amer Khoury, director of French pharmaceutical group Sanofi-Aventis site in Lisieux, poses, on October 28, 2009, in Lisieux. The site, created in 1982, is dedicated to the production of medicine containing paracetamol.

    View Photo »
  19. View taken on October 28, 2009 shows suppositories of Doliprane, a French over-the-counter drug containing paracetamol, during its production, at French pharmaceutical group Sanofi-Aventis site in Lisieux, northern France. Getty Images logo Getty Images 1 month ago

    View taken on October 28, 2009 shows suppositories of Doliprane, a French over-the-counter drug containing paracetamol, during its production, at French pharmaceutical group Sanofi-Aventis site in Lisieux, northern France.

    View Photo »
  20. View taken on October 28, 2009 shows suppositories of Doliprane, a French over-the-counter drug containing paracetamol, during its production, at French pharmaceutical group Sanofi-Aventis site in Lisieux, northern France. Getty Images logo Getty Images 1 month ago

    View taken on October 28, 2009 shows suppositories of Doliprane, a French over-the-counter drug containing paracetamol, during its production, at French pharmaceutical group Sanofi-Aventis site in Lisieux, northern France.

    View Photo »
  21. View taken on October 28, 2009 shows suppositories of Doliprane, a French over-the-counter drug containing paracetamol, during its production, at French pharmaceutical group Sanofi-Aventis site in Lisieux, northern France. Getty Images logo Getty Images 1 month ago

    View taken on October 28, 2009 shows suppositories of Doliprane, a French over-the-counter drug containing paracetamol, during its production, at French pharmaceutical group Sanofi-Aventis site in Lisieux, northern France.

    View Photo »
  22. View taken on October 28, 2009 shows suppositories of Doliprane, a French over-the-counter drug containing paracetamol, during its production, at French pharmaceutical group Sanofi-Aventis site in Lisieux, northern France. Getty Images logo Getty Images 1 month ago

    View taken on October 28, 2009 shows suppositories of Doliprane, a French over-the-counter drug containing paracetamol, during its production, at French pharmaceutical group Sanofi-Aventis site in Lisieux, northern France.

    View Photo »
  23. A person works in the production unit of Doliprane, a French over-the-counter drug containing paracetamol, on October 28, 2009 at French pharmaceutical group Sanofi-Aventis site in Lisieux, northern France. Getty Images logo Getty Images 1 month ago

    A person works in the production unit of Doliprane, a French over-the-counter drug containing paracetamol, on October 28, 2009 at French pharmaceutical group Sanofi-Aventis site in Lisieux, northern France.

    View Photo »
  24. A person works in the production unit of Doliprane, a French over-the-counter drug containing paracetamol, on October 28, 2009 at French pharmaceutical group Sanofi-Aventis site in Lisieux, northern France. Getty Images logo Getty Images 1 month ago

    A person works in the production unit of Doliprane, a French over-the-counter drug containing paracetamol, on October 28, 2009 at French pharmaceutical group Sanofi-Aventis site in Lisieux, northern France.

    View Photo »
  25. View taken on October 28, 2009 shows pills of Doliprane, a French over-the-counter drug containing paracetamol, during its production, at French pharmaceutical group Sanofi-Aventis site in Lisieux, northern France. Getty Images logo Getty Images 1 month ago

    View taken on October 28, 2009 shows pills of Doliprane, a French over-the-counter drug containing paracetamol, during its production, at French pharmaceutical group Sanofi-Aventis site in Lisieux, northern France.

    View Photo »
next
Reuters Pictures 2 months ago

Chief Executive Officer Chris Veihbacher of French drugs group Sanofi Aventis speaks during a news conference in Paris, September 24, 2009. Sanofi announced the results of the collaborative AIDS vaccine trial that has been conducted in Thailand over the past six years.

View Photo »
View All »

Related Topics

  1. Swine Flu Swine Flu
  2. GlaxoSmithKline Inc GlaxoSmithKline Inc
  3. Bristol-Myers Squibb Bristol-Myers Squibb
  4. H1N1 H1N1
  5. US Food and Drug Administration
  6. Pfizer Inc. Pfizer Inc.

Timeline of Coverage

  1. Click to see all coverage from Oct 13, 2009
    22
    October 13, 2009
  2. Click to see all coverage from Oct 14, 2009
    16
    October 14, 2009
  3. Click to see all coverage from Oct 15, 2009
    12
    October 15, 2009
  4. Click to see all coverage from Oct 16, 2009
    18
    October 16, 2009
  5. Click to see all coverage from Oct 17, 2009
    8
    October 17, 2009
  6. Click to see all coverage from Oct 18, 2009
    3
    October 18, 2009
  7. Click to see all coverage from Oct 19, 2009
    7
    October 19, 2009
  8. Click to see all coverage from Oct 20, 2009
    23
    October 20, 2009
  9. Click to see all coverage from Oct 21, 2009
    54
    October 21, 2009
  10. Click to see all coverage from Oct 22, 2009
    36
    October 22, 2009
  11. Click to see all coverage from Oct 23, 2009
    134
    October 23, 2009
  12. Click to see all coverage from Oct 24, 2009
    6
    October 24, 2009
  13. Click to see all coverage from Oct 25, 2009
    4
    October 25, 2009
  14. Click to see all coverage from Oct 26, 2009
    9
    October 26, 2009
  15. Click to see all coverage from Oct 27, 2009
    24
    October 27, 2009
  16. Click to see all coverage from Oct 28, 2009
    20
    October 28, 2009
  17. Click to see all coverage from Oct 29, 2009
    29
    October 29, 2009
  18. Click to see all coverage from Oct 30, 2009
    56
    October 30, 2009
  19. Click to see all coverage from Oct 31, 2009
    7
    October 31, 2009
  20. Click to see all coverage from Nov 01, 2009
    7
    November 01, 2009
  21. Click to see all coverage from Nov 02, 2009
    40
    November 02, 2009
  22. Click to see all coverage from Nov 03, 2009
    21
    November 03, 2009
  23. Click to see all coverage from Nov 04, 2009
    16
    November 04, 2009
  24. Click to see all coverage from Nov 05, 2009
    17
    November 05, 2009
  25. Click to see all coverage from Nov 06, 2009
    36
    November 06, 2009
  26. Click to see all coverage from Nov 07, 2009
    6
    November 07, 2009
  27. Click to see all coverage from Nov 08, 2009
    2
    November 08, 2009
  28. Click to see all coverage from Nov 09, 2009
    14
    November 09, 2009
  29. Click to see all coverage from Nov 10, 2009
    36
    November 10, 2009
  30. Click to see all coverage from Nov 11, 2009
    54
    November 11, 2009
  31. Click to see all coverage from Nov 12, 2009
    41
    November 12, 2009
  32. Click to see all coverage from Nov 13, 2009
    7
    November 13, 2009
  33. Click to see all coverage from Nov 14, 2009
    2
    November 14, 2009
  34. Click to see all coverage from Nov 15, 2009
    4
    November 15, 2009
  35. Click to see all coverage from Nov 16, 2009
    22
    November 16, 2009
  36. Click to see all coverage from Nov 17, 2009
    82
    November 17, 2009
  37. Click to see all coverage from Nov 18, 2009
    40
    November 18, 2009
  38. Click to see all coverage from Nov 19, 2009
    47
    November 19, 2009
  39. Click to see all coverage from Nov 20, 2009
    25
    November 20, 2009
  40. Click to see all coverage from Nov 21, 2009
    3
    November 21, 2009
  41. Click to see all coverage from Nov 22, 2009
    8
    November 22, 2009
  42. Click to see all coverage from Nov 23, 2009
    15
    November 23, 2009
  43. Click to see all coverage from Nov 24, 2009
    19
    November 24, 2009
  44. Click to see all coverage from Nov 25, 2009
    9
    November 25, 2009
  45. Click to see all coverage from Nov 26, 2009
    0
    November 26, 2009
  46. Click to see all coverage from Nov 27, 2009
    0
    November 27, 2009
  47. Click to see all coverage from Nov 28, 2009
    1
    November 28, 2009
  48. Click to see all coverage from Nov 29, 2009
    0
    November 29, 2009

Related Videos

  1. YouTube
  2. Videosurf
  3. Truveo
  1. Loading video...
    1. Watch video
      Wallstrip - Sanofi-Aventis
      37 months ago
    2. Watch video
      Sanofi Aventis Corporate Video
      6 months ago
    3. Watch video
      Huntingdon Life Sciences SANOFI AVENTIS office...
      15 months ago
    4. Watch video
      Sanofi-Aventis & Sanofi Pasteur Press Conferenc...
      1 month ago
    5. Watch video
      Sanofi Aventis - pubblicità doppiate
      6 months ago
    6. Watch video
      Sanofi Aventis - Corporate Video
      13 months ago
    View All YouTube Videos »
    1. Watch video
      Sanofi Aventis puts Piramal on the radar
      9 months ago
    2. Watch video
      Huntingdon Life Sciences SANOFI AVENTIS office...
      15 months ago
    3. Watch video
      Sanofi-Aventis, Regeneron Expand Partnership
      2 weeks ago
    4. Watch video
      Sanofi-Aventis CEO on Strategy
      9 months ago
    5. Watch video
      Sanofi-aventis Canada annonce la nomination de...
      2 months ago
    6. Watch video
      Sanofi-Aventis CEO on Drug Pipeline
      4 months ago
    View All Videosurf Videos »
  3. Powered by Truveo
    1. Watch video
      Nov 20: Chris Viehbacher of Sanofi-Aventis
      4 days ago
    2. Watch video
      Nov 20: Sanofi-Aventis under the spotlight
      4 days ago
    3. Watch video
      Sanofi-Aventis CEO on Drug Pipeline
      4 months ago
    4. Watch video
      Sanofi-Aventis CEO on Strategy
      9 months ago
    5. Watch video
      Sanofi-Aventis CEO on Swine Flu Pandemic
      5 months ago
    6. Watch video
      SNY Out with H1N1 Test Results
      2 weeks ago
    View All Truveo Videos »

Related Quotes

  • Previous
  • Next
  • 1/9
  1. These recommendations are based upon recently submitted studies by the manufacturer of clopidogrel [Sanofi-Aventis and Bristol-Myers Squibb]
    SOURCE: MedicineNet 1 week ago
  2. Four international vaccine manufacturers — Novartis, GlaxoSmithKline (GSK), Sanofi-Aventis and Baxter International — have quoted rates to the government
    SOURCE: Hindustan Times 2 weeks ago
  3. PARP inhibitors, which include Sanofi-Aventis's BSI-201 and AstraZeneca's olaparib, could dramatically improve prognoses for the woefully underserved patient subgroups with DNA-repair-deficient tumors
    SOURCE: News-Medical.net 2 weeks ago
  4. These are exciting times for GeoVax and everyone involved in HIV/AIDS vaccine development ... The recently announced success of a Thailand-based Phase 3 trial for an HIV/AIDS vaccine candidate owned by Sanofi-Aventis and Global Solutions for Infectious Diseases is encouraging to us all and has brought r...
    SOURCE: Street Insider 3 weeks ago
  5. Look at Edward Jones. Pfizer. You have companies like (drugmaker) Sanofi Aventis that people are just unaware of but has one of its biggest facilities in St. Louis ... Boeing is huge.
    SOURCE: St. Louis Post-Dispatch 4 weeks ago
  6. The detail of the distribution and country list is not yet available; however, few countries will be priority to receive the donated vaccines. To date, a pledge for donation of 150 million doses of pandemic vaccines has been made to developing countries, through WHO, from two companies, Glaxo Smith Klin...
    SOURCE: Trinidad and Tobago Express 1 month ago
  7. Four international vaccine manufacturers have shown interest — GSK, Novartis, Baxter and recently, Sanofi Aventis — in doing clinical trials called ‘bridge trails’ in India once we make a commitment to purchase a minimum amount
    SOURCE: Hindustan Times 2 months ago
  8. This acquisition strengthens Sanofi-Aventis' position in the attractive animal health market ... It illustrates our strategy to grow and diversify our business in order to become a global diversified healthcare leader.
    SOURCE: Canoe 2 months ago
  9. Sanofi-Aventis is prepared to make a fundamental shift in the way we do business in Canada, stepping away from the traditional pharmaceutical model and rethinking our most basic assumptions in order to build a sustainable long-term business model
    SOURCE: Canadian Business Online 2 months ago
View All »